COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1663: Articles 16621-16630  | Next

A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance
Karim, M. A., Shilts, J., Schwartzentruber, J., Hayhurst, J., Buniello, A., Mohammed, E. S. E., Zheng, J., Holmes, M. V., Ochoa, D., Carmona, M., Maranville, J., Gaunt, T. R., Emilsson, V., Gudnason, V., McDonagh, E. M., Wright, G. J., Ghoussaini, M., Dunham, I.
10.1101/2021.03.15.21253625 — Posted: 2021-03-17
Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics
Wong, S.-Y., Gold, S., Accorsi, E. K., Cowger, T. L., Wiseman, D., Navalurkar, R., Dixon, R., Helmus, D. S., CiTI Study Group, , Firpo-Betancourt, A., Mendu, D. R., Zolla-Pazner, S., Cadwell, K., Colombel, J.-F.
10.1101/2021.03.15.21253615 — Posted: 2021-03-17
Using Machine Learning along with Data Science algorithms to pre-process and forecast COVID-19 Cases and Deaths
Choudhary, A.
10.1101/2021.03.15.21253571 — Posted: 2021-03-17
Evaluation of RNA extraction free method for detection of SARS-COV-2 in salivary samples for mass screening for COVID-19
Mahmoud, D. S., Ibrahim, M. E., Ganesan, S., Thakre, D. B., Teddy, D. J., Raheja, M. P., Zaher, D. W.
10.1101/2021.03.15.21253570 — Posted: 2021-03-17
Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif
Hauser, B. M., Sangesland, M., St. Denis, K., Feldman, J., Lam, E. C., Kannegieter, T., Balazs, A. B., Lingwood, D., Schmidt, A. G.
10.1101/2021.03.15.435440 — Posted: 2021-03-16
Replication kinetic, cell tropism and associated immune responses in SARS-CoV-2 and H5N1 virus infected human iPSC derived neural models
Bauer, L., Lendemeijer, B., Leijten, L., Embregts, C. W. E., Rockx, B., Kushner, S. A., de Vrij, F. M. S., van Riel, D.
10.1101/2021.03.15.435472 — Posted: 2021-03-16
Killed whole genome-reduced bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model
Maeda, D. L. N. F., Tian, D., Yu, H., Dar, N., Rajasekaran, V., Meng, S., Mahsoub, H., Sooryanarain, H., Wang, B., Heffron, C. L., Hassebroek, A., LeRoith, T., Meng, X.-J., Zeichner, S. L.
10.1101/2021.03.15.435497 — Posted: 2021-03-16
Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants
Qu, L., Yi, Z., Shen, Y., Xu, Y., Wu, Z., Tang, H., Xiao, X., Dong, X., Guo, L., Yisimayi, A., Cao, Y., Zhou, Z., Wang, J., Xie, X. S., Wei, W.
10.1101/2021.03.16.435594 — Posted: 2021-03-16
Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay
Xia, Z., Sacco, M., Ma, C., Townsend, J., Kitamura, N., Hu, Y., Ba, M., Szeto, T., Zhang, X., Meng, X., Zhang, F., Xiang, Y., Marty, M., Chen, Y., Wang, J.
10.1101/2021.03.15.435551 — Posted: 2021-03-16
phastSim: efficient simulation of sequence evolution for pandemic-scale datasets
De Maio, N., Weilguny, L., Walker, C. R., Turakhia, Y., Corbett-Detig, R., Goldman, N.
10.1101/2021.03.15.435416 — Posted: 2021-03-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).